Ganser A - Search Results

1

Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening.

Sharma A, Jyotsana N, Lai CK, Chaturvedi A, Gabdoulline R, Görlich K, Murphy C, Blanchard JE, Ganser A, Brown E, Hassell JA, Humphries RK, Morgan M, Heuser M. Sharma A, et al. Among authors: ganser a. Curr Cancer Drug Targets. 2016;16(9):818-828. doi: 10.2174/1568009616666160617103301. Curr Cancer Drug Targets. 2016. PMID: 27321378

2

Use of hematopoietic growth factors in the treatment of acute myelogenous leukemia.

Ganser A, Heil G. Ganser A, et al. Curr Opin Hematol. 1997 May;4(3):191-5. doi: 10.1097/00062752-199704030-00006. Curr Opin Hematol. 1997. PMID: 9209835 Review.

3

Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia.

Morgan MA, Ganser A, Reuter CW. Morgan MA, et al. Among authors: ganser a. Leukemia. 2003 Aug;17(8):1482-98. doi: 10.1038/sj.leu.2403024. Leukemia. 2003. PMID: 12886235 Review.

4

Synergistic cytotoxic effects in myeloid leukemia cells upon cotreatment with farnesyltransferase and geranylgeranyl transferase-I inhibitors.

Morgan MA, Wegner J, Aydilek E, Ganser A, Reuter CW. Morgan MA, et al. Among authors: ganser a. Leukemia. 2003 Aug;17(8):1508-20. doi: 10.1038/sj.leu.2403022. Leukemia. 2003. PMID: 12886237

5

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.

Krauter J, Gorlich K, Ottmann O, Lubbert M, Dohner H, Heit W, Kanz L, Ganser A, Heil G. Krauter J, et al. Among authors: ganser a. J Clin Oncol. 2003 Dec 1;21(23):4413-22. doi: 10.1200/JCO.2003.03.166. J Clin Oncol. 2003. PMID: 14645432

6

Colony-stimulating factors in the management of neutropenia and its complications.

Heuser M, Ganser A. Heuser M, et al. Among authors: ganser a. Ann Hematol. 2005 Oct;84(11):697-708. doi: 10.1007/s00277-005-1087-4. Epub 2005 Jul 27. Ann Hematol. 2005. PMID: 16047204 Review.

7

Recombinant human erythropoietin in the treatment of nonrenal anemia.

Heuser M, Ganser A. Heuser M, et al. Among authors: ganser a. Ann Hematol. 2006 Feb;85(2):69-78. doi: 10.1007/s00277-005-1086-5. Epub 2005 Aug 3. Ann Hematol. 2006. PMID: 16078035 Review.

8

Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.

Morgan MA, Sebil T, Aydilek E, Peest D, Ganser A, Reuter CW. Morgan MA, et al. Among authors: ganser a. Br J Haematol. 2005 Sep;130(6):912-25. doi: 10.1111/j.1365-2141.2005.05696.x. Br J Haematol. 2005. PMID: 16156861 Free article.

9

Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.

Heuser M, Wingen LU, Steinemann D, Cario G, von Neuhoff N, Tauscher M, Bullinger L, Krauter J, Heil G, Döhner H, Schlegelberger B, Ganser A. Heuser M, et al. Among authors: ganser a. Haematologica. 2005 Nov;90(11):1484-92. Haematologica. 2005. PMID: 16266895

10

Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML).

Scherr M, Chaturvedi A, Battmer K, Dallmann I, Schultheis B, Ganser A, Eder M. Scherr M, et al. Among authors: ganser a. Blood. 2006 Apr 15;107(8):3279-87. doi: 10.1182/blood-2005-08-3087. Epub 2005 Nov 8. Blood. 2006. PMID: 16278304 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

886 results

Search Page

Filters